Real-world Study on Bemiparin Effect in Patients with Cancer-Associated Thromboembolism Using Artificial Intelligence (BEMICAT Study)

12/05/2025
08/08/2025
EU PAS number:
EUPAS1000000578
Study
Ongoing
Documents
Study protocol
Initial protocol
English (2.62 MB - PDF) View document
Updated protocol
English (2.03 MB - PDF) View document
Study results
Study report
Other information